C4 Therapeutics Files 8-K on Security Holder Vote
Ticker: CCCC · Form: 8-K · Filed: Jun 21, 2024 · CIK: 1662579
| Field | Detail |
|---|---|
| Company | C4 Therapeutics, Inc. (CCCC) |
| Form Type | 8-K |
| Filed Date | Jun 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
C4Tx shareholders voted on something important June 20th. Details to follow.
AI Summary
C4 Therapeutics, Inc. filed an 8-K on June 21, 2024, reporting on a matter submitted to a vote of its security holders. The filing indicates a meeting or vote occurred on June 20, 2024. The company, incorporated in Delaware, is in the biological products sector.
Why It Matters
This filing signals a formal decision-making event involving C4 Therapeutics' shareholders, which could have implications for the company's future direction or governance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain immediate financial or operational risks.
Key Players & Entities
- C4 Therapeutics, Inc. (company) — Registrant
- June 21, 2024 (date) — Date of Report
- June 20, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
FAQ
What specific matter was submitted for a vote of C4 Therapeutics' security holders?
The filing does not specify the exact matter submitted for a vote, only that a submission occurred on or before June 20, 2024.
When did the event related to the security holder vote take place?
The earliest event reported in the filing occurred on June 20, 2024.
What is C4 Therapeutics, Inc.'s primary business sector?
C4 Therapeutics, Inc. is in the Biological Products (No Diagnostic Substances) sector, SIC code 2836.
In which state is C4 Therapeutics, Inc. incorporated?
C4 Therapeutics, Inc. is incorporated in Delaware.
What is the principal executive office address for C4 Therapeutics, Inc.?
The principal executive offices are located at 490 Arsenal Way, Suite 120, Watertown, MA 02472.
Filing Stats: 616 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-06-21 16:06:43
Key Financial Figures
- $0.0001 — ange on which registered Common Stock, $0.0001 par value per share CCCC The Nasdaq Glo
Filing Documents
- cccc-20240621.htm (8-K) — 39KB
- 0001628280-24-029301.txt ( ) — 164KB
- cccc-20240621.xsd (EX-101.SCH) — 2KB
- cccc-20240621_lab.xml (EX-101.LAB) — 22KB
- cccc-20240621_pre.xml (EX-101.PRE) — 13KB
- cccc-20240621_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. C4 Therapeutics, Inc. Date: June 21, 2024 By: /s/ Jolie M. Siegel Jolie M. Siegel Chief Legal Officer